1. Home
  2. CHE vs PTCT Comparison

CHE vs PTCT Comparison

Compare CHE & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CHE

Chemed Corp

HOLD

Current Price

$368.43

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$66.13

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHE
PTCT
Founded
1970
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.5B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
CHE
PTCT
Price
$368.43
$66.13
Analyst Decision
Buy
Buy
Analyst Count
4
16
Target Price
$498.00
$80.94
AVG Volume (30 Days)
282.3K
959.7K
Earning Date
04-22-2026
05-05-2026
Dividend Yield
0.65%
N/A
EPS Growth
N/A
264.48
EPS
18.34
7.78
Revenue
$2,529,978,000.00
$264,734,000.00
Revenue This Year
$6.60
N/A
Revenue Next Year
$6.15
$19.30
P/E Ratio
$20.26
$8.61
Revenue Growth
4.06
36.19
52 Week Low
$368.44
$35.95
52 Week High
$623.61
$87.50

Technical Indicators

Market Signals
Indicator
CHE
PTCT
Relative Strength Index (RSI) 25.08 47.92
Support Level N/A $61.43
Resistance Level $458.07 $69.29
Average True Range (ATR) 8.82 2.35
MACD -1.58 0.38
Stochastic Oscillator 6.19 50.28

Price Performance

Historical Comparison
CHE
PTCT

About CHE Chemed Corp

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: